Health Technology Assessment

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer

  • Type:
    Extended Research Article
  • Authors:
    Collins R, Fenwick E, Trowman R, Perard R, Norman G, et al.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 11, Issue: 2
  • Published:
  • Citation:
    Collins R, Fenwick E, Trowman R, Perard R, Norman G, et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. Health Technol Assess 2007;11(2). https://doi.org/10.3310/hta11020
  • DOI:
    https://doi.org/10.3310/hta11020
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates